Tompkins et al., 1995 - Google Patents
The new path to preventing ulcersTompkins et al., 1995
- Document ID
- 8047782861587304701
- Author
- Tompkins L
- Falkow S
- Publication year
- Publication venue
- Science
External Links
Snippet
1621 the invasive tactics employed by H. pylori to establish itself in the forbidding environment of the stomach. Helicobacter moves by five-or six-polar flagella into the mucous layer overlying the gastric epithelium. A potent urease produced by the microorganism is …
- 206010068760 Ulcers 0 title abstract description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tompkins et al. | The new path to preventing ulcers | |
| Montecucco et al. | Living dangerously: how Helicobacter pylori survives in the human stomach | |
| Figura | Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. | |
| Guyer et al. | Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli | |
| Weel et al. | The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases | |
| Vallance et al. | Enteropathogenic and enterohemorrhagic Escherichia coli infections: emerging themes in pathogenesis and prevention | |
| Sha et al. | The two murein lipoproteins of Salmonella enterica serovar Typhimurium contribute to the virulence of the organism | |
| Smoot et al. | Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells. | |
| Gómez-Duarte et al. | The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases | |
| Liu | Brucella | |
| Pier et al. | Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies | |
| US5798260A (en) | Escherichia coli O157:H7 epithelial adhesin | |
| Blaser | Role of the S-Layer Proteins of Campylobacter fetus in Serum-Resistance and AntigenicVariation: A Model of Bacterial Pathogenesis | |
| AU2010201664A1 (en) | Live attenuated salmonella for use as vaccine | |
| Marchetti et al. | Isogenic mutants of the cag pathogenicity island of Helicobacter pylori in the mouse model of infection: effects on colonization efficiency | |
| Ruiz-Bustos et al. | Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H. pylori heparan sulphate-binding proteins coupled to cholera toxin β-subunit | |
| Kleanthous et al. | Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent | |
| Vyas et al. | Exploring novel vaccines against Helicobacter pylori: protective and therapeutic immunization | |
| Trust et al. | Helicobacter pylori: today's treatment, and possible future treatment | |
| US20220218810A1 (en) | New immunogenic compositions | |
| Figura et al. | H. pylori vacuolating toxin | |
| Dugan | Bacteria | |
| Mariner et al. | The dynamics of CBPP endemism and development of effective control strategies | |
| Rijpkema et al. | Analysis of host responses of guinea pigs during Helicobacter pylori infection | |
| Ghiara et al. | Development of a vaccine |